The global Conjugate Vaccine revenue was US$ 9995.1 million in 2022 and is forecast to a readjusted size of US$ 12490 million by 2029 with a CAGR of 3.2% during the forecast period (2023-2029).

and India Conjugate Vaccine Market

Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.

In India, the Conjugate Vaccine revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

Market competition is intense. Pfizer, GSK, Sanofi, Merck, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 86.11% market share in 2019.

This report focuses on global and India Conjugate Vaccine market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Conjugate Vaccine will continue to grow rapidly in the future.

Global Conjugate Vaccine Scope and Market Size

Conjugate Vaccine market is segmented in regional and country, by players, by type and by end users. Companies, stakeholders, and other participants in the global Conjugate Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by end users for the period 2018-2029.

For India market, this report focuses on the Conjugate Vaccine market size by players, by Type and by End Users, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Conjugate Vaccine Market Report

Report Metric	Details
Report Name	and India Conjugate Vaccine Market
Forecasted market size in 2029	US$ 12490 million
CAGR	3.2%
Forecasted years	2023 - 2029
Segment by Type	Hib Vaccine Meningococcal Vaccine Pneumococcal Vaccine Others
Segment by End Users	Children Adult
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Bharat Biotech, Zhifei Biologic
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Conjugate Vaccine Market size in 2029?

Ans: The and India Conjugate Vaccine Market size in 2029 will be US$ 12490 million.

What is the market share of major companies in and India Conjugate Vaccine Market?

Ans: Top 5 manufacturers accounted for 86.11% market share in 2019.

What is the and India Conjugate Vaccine Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Conjugate Vaccine Market report?

Ans: The main players in the and India Conjugate Vaccine Market are Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Bharat Biotech, Zhifei Biologic

What are the Type segmentation covered in the and India Conjugate Vaccine Market report?

Ans: The Types covered in the and India Conjugate Vaccine Market report are Hib Vaccine, Meningococcal Vaccine, Pneumococcal Vaccine, Others

What are the End User segmentation covered in the and India Conjugate Vaccine Market report?

Ans: The End users covered in the and India Conjugate Vaccine Market report are Children, Adult

1 Study Coverage

1.1 Conjugate Vaccine Product Introduction

1.2 Global Conjugate Vaccine Outlook 2018 VS 2022 VS 2029

1.2.1 Global Conjugate Vaccine Sales in US$ Million for the Year 2018-2029

1.2.2 Global Conjugate Vaccine Sales in Volume for the Year 2018-2029

1.3 India Conjugate Vaccine Outlook 2018 VS 2022 VS 2029

1.3.1 India Conjugate Vaccine Sales in US$ Million for the Year 2018-2029

1.3.2 India Conjugate Vaccine Sales in Volume for the Year 2018-2029

1.4 Conjugate Vaccine Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Conjugate Vaccine in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Conjugate Vaccine Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Conjugate Vaccine Market Dynamics

1.5.1 Conjugate Vaccine Industry Trends

1.5.2 Conjugate Vaccine Market Drivers

1.5.3 Conjugate Vaccine Market Challenges

1.5.4 Conjugate Vaccine Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2 Conjugate Vaccine by Type

2.1 Conjugate Vaccine Market Segment by Type

2.1.1 Hib Vaccine

2.1.2 Meningococcal Vaccine

2.1.3 Pneumococcal Vaccine

2.1.4 Others

2.2 Global Conjugate Vaccine Market Size by Type

2.2.1 Global Conjugate Vaccine Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Conjugate Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Conjugate Vaccine Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Conjugate Vaccine Market Size by Type

2.3.1 India Conjugate Vaccine Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Conjugate Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Conjugate Vaccine Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3 Conjugate Vaccine by End Users

3.1 Conjugate Vaccine Market Segment by End Users

3.1.1 Children

3.1.2 Adult

3.2 Global Conjugate Vaccine Market Size by End Users

3.2.1 Global Conjugate Vaccine Sales in Value, by End Users (2018, 2022 & 2029)

3.2.2 Global Conjugate Vaccine Sales in Volume, by End Users (2018, 2022 & 2029)

3.3.3 Global Conjugate Vaccine Average Selling Price (ASP) by End Users (2018, 2022 & 2029)

3.3 India Conjugate Vaccine Market Size by End Users

3.3.1 India Conjugate Vaccine Sales in Value, by End Users (2018, 2022 & 2029)

3.3.2 India Conjugate Vaccine Sales in Volume, by End Users (2018, 2022 & 2029)

3.3.3 India Conjugate Vaccine Average Selling Price (ASP) by End Users (2018, 2022 & 2029)

4 Global Conjugate Vaccine Competitor Landscape by Company

4.1 Global Conjugate Vaccine Market Size by Company

4.1.1 Global Key Manufacturers of Conjugate Vaccine, Ranked by Revenue (2022)

4.1.2 Global Conjugate Vaccine Revenue by Manufacturer (2018-2023)

4.1.3 Global Conjugate Vaccine Sales by Manufacturer (2018-2023)

4.1.4 Global Conjugate Vaccine Price by Manufacturer (2018-2023)

4.2 Global Conjugate Vaccine Concentration Ratio (CR)

4.2.1 Conjugate Vaccine Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Conjugate Vaccine in 2022

4.2.3 Global Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Conjugate Vaccine, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Conjugate Vaccine, Product Offered and Application

4.5 Global Key Manufacturers of Conjugate Vaccine, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Conjugate Vaccine Market Size by Company

4.7.1 Key Players of Conjugate Vaccine in India, Ranked by Revenue (2022)

4.7.2 India Conjugate Vaccine Revenue by Players (2018-2023)

4.7.3 India Conjugate Vaccine Sales by Players (2018-2023)

5 Global Conjugate Vaccine Market Size by Region

5.1 Global Conjugate Vaccine Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Conjugate Vaccine Market Size in Volume by Region (2018-2029)

5.2.1 Global Conjugate Vaccine Sales in Volume by Region: 2018-2023

5.2.2 Global Conjugate Vaccine Sales in Volume Forecast by Region (2024-2029)

5.3 Global Conjugate Vaccine Market Size in Value by Region (2018-2029)

5.3.1 Global Conjugate Vaccine Sales in Value by Region: 2018-2023

5.3.2 Global Conjugate Vaccine Sales in Value by Region: 2024-2029

6 Americas

6.1 Americas Conjugate Vaccine Market Size YoY Growth 2018-2029

6.2 Americas Conjugate Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Conjugate Vaccine Sales in Volume, by End Users (2018, 2022 & 2029)

6.4 Americas Conjugate Vaccine Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Conjugate Vaccine Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Conjugate Vaccine Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Conjugate Vaccine Market Size YoY Growth 2018-2029

7.2 EMEA Conjugate Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Conjugate Vaccine Sales in Volume, by End Users (2018, 2022 & 2029)

7.4 EMEA Conjugate Vaccine Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Conjugate Vaccine Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Conjugate Vaccine Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Conjugate Vaccine Market Size YoY Growth 2018-2029

8.2 China Conjugate Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Conjugate Vaccine Sales in Volume, by End Users (2018, 2022 & 2029)

9 APAC

9.1 APAC Conjugate Vaccine Market Size YoY Growth 2018-2029

9.2 APAC Conjugate Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Conjugate Vaccine Sales in Volume, by End Users (2018, 2022 & 2029)

9.4 APAC Conjugate Vaccine Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Conjugate Vaccine Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Conjugate Vaccine Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Pfizer

10.1.1 Pfizer Company Information

10.1.2 Pfizer Description and Business Overview

10.1.3 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Pfizer Conjugate Vaccine Products Offered

10.1.5 Pfizer Recent Development

10.2 GSK

10.2.1 GSK Company Information

10.2.2 GSK Description and Business Overview

10.2.3 GSK Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.2.4 GSK Conjugate Vaccine Products Offered

10.2.5 GSK Recent Development

10.3 Sanofi

10.3.1 Sanofi Company Information

10.3.2 Sanofi Description and Business Overview

10.3.3 Sanofi Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Sanofi Conjugate Vaccine Products Offered

10.3.5 Sanofi Recent Development

10.4 Merck

10.4.1 Merck Company Information

10.4.2 Merck Description and Business Overview

10.4.3 Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Merck Conjugate Vaccine Products Offered

10.4.5 Merck Recent Development

10.5 Walvax Biotechnology

10.5.1 Walvax Biotechnology Company Information

10.5.2 Walvax Biotechnology Description and Business Overview

10.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Walvax Biotechnology Conjugate Vaccine Products Offered

10.5.5 Walvax Biotechnology Recent Development

10.6 Royal (Wuxi) Bio-Pharmaceutical

10.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information

10.6.2 Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview

10.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Products Offered

10.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development

10.7 Bharat Biotech

10.7.1 Bharat Biotech Company Information

10.7.2 Bharat Biotech Description and Business Overview

10.7.3 Bharat Biotech Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Bharat Biotech Conjugate Vaccine Products Offered

10.7.5 Bharat Biotech Recent Development

10.8 Zhifei Biologic

10.8.1 Zhifei Biologic Company Information

10.8.2 Zhifei Biologic Description and Business Overview

10.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Zhifei Biologic Conjugate Vaccine Products Offered

10.8.5 Zhifei Biologic Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Conjugate Vaccine Industry Chain Analysis

11.2 Conjugate Vaccine Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Conjugate Vaccine Production Mode & Process

11.4 Conjugate Vaccine Sales and Marketing

11.4.1 Conjugate Vaccine Sales Channels

11.4.2 Conjugate Vaccine Distributors

11.5 Conjugate Vaccine Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Royal (Wuxi) Bio-Pharmaceutical

Bharat Biotech

Zhifei Biologic

List of Tables

Table 1. Conjugate Vaccine CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

Table 2. Conjugate Vaccine Market Trends

Table 3. Conjugate Vaccine Market Drivers

Table 4. Conjugate Vaccine Market Challenges

Table 5. Conjugate Vaccine Market Restraints

Table 6. Global Conjugate Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Conjugate Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Conjugate Vaccine Sales Growth Rate (CAGR) by End Users: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Conjugate Vaccine Sales Growth Rate (CAGR) by End Users: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Manufacturers of Conjugate Vaccine, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Conjugate Vaccine Revenue by Manufacturer, (US$ Million), 2018-2023

Table 12. Global Conjugate Vaccine Revenue Share by Manufacturer, 2018-2023

Table 13. Global Conjugate Vaccine Sales by Manufacturer, (Million Unit), 2018-2023

Table 14. Global Conjugate Vaccine Sales Share by Manufacturer, 2018-2023

Table 15. Global Conjugate Vaccine Price by Manufacturer (2018-2023) & (USD/Unit)

Table 16. Global Conjugate Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjugate Vaccine as of 2022)

Table 18. Global Key Manufacturers of Conjugate Vaccine, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Conjugate Vaccine, Product Offered and Application

Table 20. Global Key Manufacturers of Conjugate Vaccine, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Conjugate Vaccine in India, Ranked by Revenue (2022) & (US$ million)

Table 23. India Conjugate Vaccine Revenue by Players, (US$ Million), (2018-2023)

Table 24. India Conjugate Vaccine Revenue Share by Players, (2018-2023)

Table 25. India Conjugate Vaccine Sales by Players, (Million Unit), (2018-2023)

Table 26. India Conjugate Vaccine Sales Share by Players, (2018-2023)

Table 27. Global Conjugate Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 28. Global Conjugate Vaccine Sales in Volume by Region (2018-2023) & (Million Unit)

Table 29. Global Conjugate Vaccine Sales in Volume Forecast by Region (2024-2029) & (Million Unit)

Table 30. Global Conjugate Vaccine Sales in Value by Region (2018-2023) & (US$ Million)

Table 31. Global Conjugate Vaccine Sales in Value Forecast by Region (2024-2029) & (US$ Million)

Table 32. Americas Conjugate Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. Americas Conjugate Vaccine Sales in Value by Country (2018-2023) & (US$ Million)

Table 34. Americas Conjugate Vaccine Sales in Value by Country (2024-2029) & (US$ Million)

Table 35. Americas Conjugate Vaccine Sales in Volume by Country (2018-2023) & (Million Unit)

Table 36. Americas Conjugate Vaccine Sales in Volume by Country (2024-2029) & (Million Unit)

Table 37. EMEA Conjugate Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. EMEA Conjugate Vaccine Sales in Value by Country (2018-2023) & (US$ Million)

Table 39. EMEA Conjugate Vaccine Sales in Value by Country (2024-2029) & (US$ Million)

Table 40. EMEA Conjugate Vaccine Sales in Volume by Country (2018-2023) & (Million Unit)

Table 41. EMEA Conjugate Vaccine Sales in Volume by Country (2024-2029) & (Million Unit)

Table 42. APAC Conjugate Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. APAC Conjugate Vaccine Sales in Value by Country (2018-2023) & (US$ Million)

Table 44. APAC Conjugate Vaccine Sales in Value by Country (2024-2029) & (US$ Million)

Table 45. APAC Conjugate Vaccine Sales in Volume by Country (2018-2023) & (Million Unit)

Table 46. APAC Conjugate Vaccine Sales in Volume by Country (2024-2029) & (Million Unit)

Table 47. Pfizer Company Information

Table 48. Pfizer Description and Business Overview

Table 49. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 50. Pfizer Conjugate Vaccine Product

Table 51. Pfizer Recent Development

Table 52. GSK Company Information

Table 53. GSK Description and Business Overview

Table 54. GSK Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 55. GSK Conjugate Vaccine Product

Table 56. GSK Recent Development

Table 57. Sanofi Company Information

Table 58. Sanofi Description and Business Overview

Table 59. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 60. Sanofi Conjugate Vaccine Product

Table 61. Sanofi Recent Development

Table 62. Merck Company Information

Table 63. Merck Description and Business Overview

Table 64. Merck Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 65. Merck Conjugate Vaccine Product

Table 66. Merck Recent Development

Table 67. Walvax Biotechnology Company Information

Table 68. Walvax Biotechnology Description and Business Overview

Table 69. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 70. Walvax Biotechnology Conjugate Vaccine Product

Table 71. Walvax Biotechnology Recent Development

Table 72. Royal (Wuxi) Bio-Pharmaceutical Company Information

Table 73. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview

Table 74. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 75. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product

Table 76. Royal (Wuxi) Bio-Pharmaceutical Recent Development

Table 77. Bharat Biotech Company Information

Table 78. Bharat Biotech Description and Business Overview

Table 79. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 80. Bharat Biotech Conjugate Vaccine Product

Table 81. Bharat Biotech Recent Development

Table 82. Zhifei Biologic Company Information

Table 83. Zhifei Biologic Description and Business Overview

Table 84. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 85. Zhifei Biologic Conjugate Vaccine Product

Table 86. Zhifei Biologic Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Conjugate Vaccine Customers List

Table 90. Conjugate Vaccine Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Conjugate Vaccine Product Picture

Figure 2. Global Conjugate Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Conjugate Vaccine Market Size 2018-2029 (US$ Million)

Figure 4. Global Conjugate Vaccine Sales 2018-2029 (Million Unit)

Figure 5. India Conjugate Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 6. India Conjugate Vaccine Market Size 2018-2029 (US$ Million)

Figure 7. India Conjugate Vaccine Sales 2018-2029 (Million Unit)

Figure 8. India Conjugate Vaccine Market Share in Global, in Value (US$ Million) 2018-2029

Figure 9. India Conjugate Vaccine Market Share in Global, in Volume (Million Unit) 2018-2029

Figure 10. Conjugate Vaccine Report Years Considered

Figure 11. Product Picture of Hib Vaccine

Figure 12. Product Picture of Meningococcal Vaccine

Figure 13. Product Picture of Pneumococcal Vaccine

Figure 14. Product Picture of Others

Figure 15. Global Conjugate Vaccine Market Share by Type in 2022 & 2029

Figure 16. Global Conjugate Vaccine Sales in Value by Type (2018-2029) & (US$ Million)

Figure 17. Global Conjugate Vaccine Sales Market Share in Value by Type (2018-2029)

Figure 18. Global Conjugate Vaccine Sales by Type (2018-2029) & (Million Unit)

Figure 19. Global Conjugate Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 20. Global Conjugate Vaccine Price by Type (2018-2029) & (USD/Unit)

Figure 21. India Conjugate Vaccine Market Share by Type in 2022 & 2029

Figure 22. India Conjugate Vaccine Sales in Value by Type (2018-2029) & (US$ Million)

Figure 23. India Conjugate Vaccine Sales Market Share in Value by Type (2018-2029)

Figure 24. India Conjugate Vaccine Sales by Type (2018-2029) & (Million Unit)

Figure 25. India Conjugate Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 26. India Conjugate Vaccine Price by Type (2018-2029) & (USD/Unit)

Figure 27. Product Picture of Children

Figure 28. Product Picture of Adult

Figure 29. Global Conjugate Vaccine Market Share by End Users in 2022 & 2029

Figure 30. Global Conjugate Vaccine Sales in Value by End Users (2018-2029) & (US$ Million)

Figure 31. Global Conjugate Vaccine Sales Market Share in Value by End Users (2018-2029)

Figure 32. Global Conjugate Vaccine Sales by End Users (2018-2029) & (Million Unit)

Figure 33. Global Conjugate Vaccine Sales Market Share in Volume by End Users (2018-2029)

Figure 34. Global Conjugate Vaccine Price by End Users (2018-2029) & (USD/Unit)

Figure 35. India Conjugate Vaccine Market Share by End Users in 2022 & 2029

Figure 36. India Conjugate Vaccine Sales in Value by End Users (2018-2029) & (US$ Million)

Figure 37. India Conjugate Vaccine Sales Market Share in Value by End Users (2018-2029)

Figure 38. India Conjugate Vaccine Sales by End Users (2018-2029) & (Million Unit)

Figure 39. India Conjugate Vaccine Sales Market Share in Volume by End Users (2018-2029)

Figure 40. India Conjugate Vaccine Price by End Users (2018-2029) & (USD/Unit)

Figure 41. Americas Conjugate Vaccine Sales in Volume Growth Rate 2018-2029 (Million Unit)

Figure 42. Americas Conjugate Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 43. Americas Conjugate Vaccine Sales by Type (2018-2029) & (Million Unit)

Figure 44. Americas Conjugate Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 45. Americas Conjugate Vaccine Sales by End Users (2018-2029) & (Million Unit)

Figure 46. Americas Conjugate Vaccine Sales Market Share in Volume by End Users (2018-2029)

Figure 47. United States Conjugate Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 48. Canada Conjugate Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 49. Mexico Conjugate Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 50. Brazil Conjugate Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 51. EMEA Conjugate Vaccine Sales in Volume Growth Rate 2018-2029 (Million Unit)

Figure 52. EMEA Conjugate Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 53. EMEA Conjugate Vaccine Sales by Type (2018-2029) & (Million Unit)

Figure 54. EMEA Conjugate Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 55. EMEA Conjugate Vaccine Sales by End Users (2018-2029) & (Million Unit)

Figure 56. EMEA Conjugate Vaccine Sales Market Share in Volume by End Users (2018-2029)

Figure 57. Europe Conjugate Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 58. Middle East Conjugate Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 59. Africa Conjugate Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 60. China Conjugate Vaccine Sales in Volume Growth Rate 2018-2029 (Million Unit)

Figure 61. China Conjugate Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 62. China Conjugate Vaccine Sales by Type (2018-2029) & (Million Unit)

Figure 63. China Conjugate Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 64. China Conjugate Vaccine Sales by End Users (2018-2029) & (Million Unit)

Figure 65. China Conjugate Vaccine Sales Market Share in Volume by End Users (2018-2029)

Figure 66. APAC Conjugate Vaccine Sales in Volume Growth Rate 2018-2029 (Million Unit)

Figure 67. APAC Conjugate Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 68. APAC Conjugate Vaccine Sales by Type (2018-2029) & (Million Unit)

Figure 69. APAC Conjugate Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 70. APAC Conjugate Vaccine Sales by End Users (2018-2029) & (Million Unit)

Figure 71. APAC Conjugate Vaccine Sales Market Share in Volume by End Users (2018-2029)

Figure 72. Japan Conjugate Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 73. South Korea Conjugate Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 74. China Taiwan Conjugate Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 75. Southeast Asia Conjugate Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 76. India Conjugate Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 77. Conjugate Vaccine Value Chain

Figure 78. Conjugate Vaccine Production Process

Figure 79. Channels of Distribution

Figure 80. Distributors Profiles

Figure 81. Bottom-up and Top-down Approaches for This Report

Figure 82. Data Triangulation

Figure 83. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4U20267

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global Anticoccidial Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-16R16865

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Bacterial Enteric Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-3F17301

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Whooping Cough Vaccination Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-4B20221

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global and India Conjugate Vaccine Market Report & Forecast 2023-2029

Published Date: November 2023

Report Code: QYRE-Auto-28P15753

Global and India Conjugate Vaccine Market Report & Forecast 2023-2029

FEATURED COMPANIES

and India Conjugate Vaccine Market Size

and India Conjugate Vaccine Market

Scope of and India Conjugate Vaccine Market Report

FAQ for this report

What is the and India Conjugate Vaccine Market size in 2029?

What is the market share of major companies in and India Conjugate Vaccine Market?

What is the and India Conjugate Vaccine Market share by region?

Who are the main players in the and India Conjugate Vaccine Market report?

What are the Type segmentation covered in the and India Conjugate Vaccine Market report?

What are the End User segmentation covered in the and India Conjugate Vaccine Market report?

FEATURED COMPANIES

RELATED REPORTS